Trypanosoma brucei FKBP12 differentially controls motility and cytokinesis in procyclic and bloodstream forms. - Institut Pasteur Access content directly
Journal Articles Eukaryotic Cell Year : 2013

Trypanosoma brucei FKBP12 differentially controls motility and cytokinesis in procyclic and bloodstream forms.

Abstract

FKBP12 proteins are able to inhibit TOR kinases or calcineurin phosphatases upon binding of rapamycin or FK506 drugs, respectively. The Trypanosoma brucei FKBP12 homologue (TbFKBP12) was found to be a cytoskeleton-associated protein with specific localization in the flagellar pocket area of the bloodstream form. In the insect procyclic form, RNA interference-mediated knockdown of TbFKBP12 affected motility. In bloodstream cells, depletion of TbFKBP12 affected cytokinesis and cytoskeleton architecture. These last effects were associated with the presence of internal translucent cavities limited by an inside-out configuration of the normal cell surface, with a luminal variant surface glycoprotein coat lined up by microtubules. These cavities, which recreated the streamlined shape of the normal trypanosome cytoskeleton, might represent unsuccessful attempts for cell abscission. We propose that TbFKBP12 differentially affects stage-specific processes through association with the cytoskeleton.
Fichier principal
Vignette du fichier
zek168.pdf (4.36 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

pasteur-01371316 , version 1 (25-09-2016)

Identifiers

Cite

Anaïs Brasseur, Brice Rotureau, Marjorie Vermeersch, Thierry Blisnick, Didier Salmon, et al.. Trypanosoma brucei FKBP12 differentially controls motility and cytokinesis in procyclic and bloodstream forms.. Eukaryotic Cell, 2013, 12 (2), pp.168-81. ⟨10.1128/EC.00077-12⟩. ⟨pasteur-01371316⟩

Collections

PASTEUR CNRS
113 View
175 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More